AAAAAA

   
Results: 1-8 |
Results: 8

Authors: PROWSE CV MACGREGOR IR
Citation: Cv. Prowse et Ir. Macgregor, NEOANTIGENS AND ANTIBODIES TO FACTOR-VIII, Blood reviews, 12(2), 1998, pp. 99-105

Authors: PROWSE CV
Citation: Cv. Prowse, ALTERNATIVES TO HUMAN BLOOD AND BLOOD RESOURCES, Vox sanguinis, 74, 1998, pp. 21-28

Authors: URBANIAK SJ GREISS MA PERERA WS INSKIP M FLOWITTHILL D ARMSTRONGFISHER SS TEMPLETON G DOWNING I FRASER R CARTER MC PROWSE CV
Citation: Sj. Urbaniak et al., ASSESSMENT OF IN-VIVO FUNCTION OF IGG1 AND IGG3 MONOCLONAL ANTI-D BY CLEARANCE OF TC-99 LABELED AUTOLOGOUS RHESUS-D POSITIVE RED-BLOOD-CELLS, Transfusion, 38(10), 1998, pp. 109-109

Authors: PROWSE CV URBANIAK SJ
Citation: Cv. Prowse et Sj. Urbaniak, EFFECT OF THERAPEUTIC PLASMAPHERESIS ON COAGULATION PARAMETERS, Journal of clinical apheresis, 10(2), 1995, pp. 103-103

Authors: PROWSE CV
Citation: Cv. Prowse, IN-VIVO RECOVERY OF FACTOR-VIII FOLLOWING TRANSFUSION - A SURVEY OF RECENT DATA AND PUBLICATIONS TO ASSESS THE INFLUENCE OF STANDARDS USED FOR POTENCY ASSIGNMENT, Thrombosis and haemostasis, 74(4), 1995, pp. 1191-1196

Authors: MCLAUGHLIN LF MACGREGOR IR MACGREGOR MC PEPPER DS PROWSE CV
Citation: Lf. Mclaughlin et al., ASSESSMENT OF METHODS FOR DETECTION OF NEOANTIGENS IN BLOOD PRODUCTS, Thrombosis and haemostasis, 73(6), 1995, pp. 1211-1211

Authors: MACGREGOR IR MCLAUGHLIN LF MACGREGOR MC PROWSE CV PEPPER DS
Citation: Ir. Macgregor et al., NO DETECTABLE ALTERATIONS IN IMMUNOGENICITY FOLLOWING TERMINAL SEVEREDRY-HEAT TREATMENT OF HIGH-PURITY FACTOR-VIII (LIBERATE) AND FACTOR-IX (HP9) CONCENTRATES, Vox sanguinis, 69(4), 1995, pp. 319-327

Authors: PROWSE CV
Citation: Cv. Prowse, PARVOVIRUS B19 AND BLOOD PRODUCTS, Lancet, 343(8905), 1994, pp. 1101-1101
Risultati: 1-8 |